Multi-omics of the gut microbial ecosystem in inflammatory bowel diseases
Open accessThe DOI matches its Crossref record; 100 of the 101 references it cites were found in a registry or an index.
Abstract
Inflammatory bowel diseases, which include Crohn’s disease and ulcerative colitis, affect several million individuals worldwide. Crohn’s disease and ulcerative colitis are complex diseases that are heterogeneous at the clinical, immunological, molecular, genetic, and microbial levels. Individual contributing factors have been the focus of extensive research. As part of the Integrative Human Microbiome Project (HMP2 or iHMP), we followed 132 subjects for one year each to generate integrated longitudinal molecular profiles of host and microbial activity during disease (up to 24 time points each; in total 2,965 stool, biopsy, and blood specimens). Here we present the results, which provide a comprehensive view of functional dysbiosis in the gut microbiome during inflammatory bowel disease activity. We demonstrate a characteristic increase in facultative anaerobes at the expense of obligate anaerobes, as well as molecular disruptions in microbial transcription (for example, among clostridia), metabolite pools (acylcarnitines, bile acids, and short-chain fatty acids), and levels of antibodies in host serum. Periods of disease activity were also marked by increases in temporal variability, with characteristic taxonomic, functional, and biochemical shifts. Finally, integrative analysis identified microbial, biochemical, and host factors central to this dysregulation. The study’s infrastructure resources, results, and data, which are available through the Inflammatory Bowel Disease Multi’omics Database ( http://ibdmdb.org ), provide the most comprehensive description to date of host and microbial activities in inflammatory bowel diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures













Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“This relative absence of biomarkers for active UC may result both from its generally more benign phenotype (IBDMDB Investigators et al., 2019) and from the smaller number of active UC samples (n = 23) compared with active CD samples (n = 76); as a result, we focused our subsequent analyses on expression differences within the CD subcohort.”
From Integrating taxonomic, functional, and strain-level profiling of diverse microbial communities with bioBakery 3 (2021) · cites this paper as IBDMDB Investigators et al., 2019
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“This network of mechanistic associations identified several key components that are central to the alterations seen in IBD, highlighting octanoyl carnitine, several lipids and short-chain fatty acids, the taxa Faecalibacterium, Subdoligranulum, Roseburia, Alistipes, and Escherichia, some at both the metagenomic and metatranscriptomic levels, and host regulators of interleukins49.”
From The Integrative Human Microbiome Project (2019) · cites this paper as [49]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Multiple lines of evidence point towards central roles of gut microbiome perturbations in the pathogenesis of IBD.”
From Interaction between microbiota and immunity in health and disease (2020) · cites this paper as [152]
The cited source says what the claim attributes to it.
In the citing paper
“These studies, which have now reached the first stage of completion49–51, together provide a wealth of information and insights about not only microbial dynamics, but also associated human host responses and microbial inter-relationships.”
From The Integrative Human Microbiome Project (2019) · cites this paper as [49]
In the citing paper
“The authors could then use the 17 top taxa in their ranked list to identify which individuals are dysbiotic, an approach that demonstrated similar or better performance than the GMWI2 or another published metric called the “dysbiotic score”.195”
From Gut dysbiosis in oncology: a risk factor for immunoresistance (2026) · doi:10.1038/s41422-025-01212-6 · cites this paper as [195]
7 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cytoscape: A software Environment for integrated models of biomolecular interaction networks
Shannon, P., Markiel, A., Ozier, O., Baliga, N. S., Wang, J. T., Ramage, D., Amin, N., Schwikowski, B., & Ideker, T. (2003) · Genome Research · doi:10.1101/gr.1239303 · Cited by 51,888
Robinson, M. D., McCarthy, D. J., & Smyth, G. K. (2010) · Bioinformatics · doi:10.1093/bioinformatics/btp616 · Cited by 41,364
limma powers differential expression analyses for RNA-sequencing and microarray studies
Ritchie, M. E., Phipson, B., Wu, D., Hu, Y., Law, C. W., Shi, W., & Smyth, G. K. (2015) · Nucleic Acids Research · doi:10.1093/nar/gkv007 · Cited by 40,458
PLINK: a tool set for whole-genome association and population-based linkage analyses.
Purcell, S., Neale, B., Todd-Brown, K., Thomas, L., Ferreira, M. A. R., Bender, D., Maller, J., Sklar, P., de Bakker, P. I. W., Daly, M. J., et al. (2007) · The American Journal of Human Genetics · doi:10.1086/519795 · Cited by 34,089
Wickham, H. (2016) · Use R! · doi:10.1007/978-3-319-24277-4 · Cited by 33,115
Search and clustering orders of magnitude faster than BLAST
Edgar, R. C. (2010) · Bioinformatics · doi:10.1093/bioinformatics/btq461 · Cited by 20,826
A global reference for human genetic variation
The 1000 Genomes Project Consortium, authors, C., Auton, A., Abecasis, G. R., Steering committee, Altshuler, D. M., Durbin, R. M., Abecasis, G. R., Bentley, D. R., Chakravarti, A., et al. (2015) · Nature · doi:10.1038/nature15393 · Cited by 18,247
Self-citationUPARSE: highly accurate OTU sequences from microbial amplicon reads
Edgar, R. C. (2013) · Nature Methods · doi:10.1038/nmeth.2604 · Cited by 16,707
ggplot2: Elegant Graphics for Data Analysis
Wickham, H. (2009) · doi:10.1007/978-0-387-98141-3 · Cited by 14,447
Fast and sensitive protein alignment using DIAMOND
Buchfink, B., Xie, C., & Huson, D. H. (2015) · Nature Methods · doi:10.1038/nmeth.3176 · Cited by 14,201
Cited by
Items 601–700 of 1,010
Gut microbiota and inflammatory bowel disease
Chen, L., & Wang, J. (2021) · WIREs Mechanisms of Disease · doi:10.1002/wsbm.1540 · Cited by 65
Yao, Q., Fan, L., Zheng, N., Blecker, C. S., Delcenserie, V., Li, H., & Wang, J. (2022) · Frontiers in Nutrition · doi:10.3389/fnut.2022.822020 · Cited by 57
“Epidemiological and clinical evidence suggest that it results from aberrant crosstalk among environmental factors, gut microbiota, and the immune system (2, 3).”
BackgroundImpact of international travel and diarrhea on gut microbiome and resistome dynamics
Boolchandani, M., Blake, K. S., Tilley, D. H., Cabada, M. M., Schwartz, D. J., Patel, S., Morales, M. L., Meza, R. A., Soto, G. M., Isidean, S. D., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-34862-w · Cited by 59
Adverse health effects of emerging contaminants on inflammatory bowel disease
Chen, X., Wang, S., Mao, X., Xiang, X., Ye, S., Chen, J., Zhu, A., Meng, Y., Yang, X., Peng, S., et al. (2023) · Frontiers in Public Health · doi:10.3389/fpubh.2023.1140786 · Cited by 68
Inflammatory Bowel Disease and Neurodegenerative Diseases
Kim, J. S., Chen, M., Wang, H. E., Lu, C., Wang, Y., & Zhang, B. (2023) · Gut and Liver · doi:10.5009/gnl220523 · Cited by 57
Wu, Y., Zheng, Y., Wang, X., Tang, P., Guo, W., Ma, H., Zhang, A., Li, D., Xie, Y., Wang, C., et al. (2023) · The American Journal of Chinese Medicine · doi:10.1142/s0192415x23500325 · Cited by 55
Enteral nutrition promotes the remission of colitis by gut bacteria-mediated histidine biosynthesis
Zeng, W., Wu, J., Xie, H., Xu, H., Liang, D., He, Q., Yang, X., Liu, C., Gong, J., Zhang, Q., et al. (2024) · EBioMedicine · doi:10.1016/j.ebiom.2023.104959 · Cited by 55
Tegegne, H. A., & Savidge, T. (2025) · Gut Microbes · doi:10.1080/19490976.2025.2569739 · Cited by 66
“3,4 This technological leap has made it possible to not only characterize microbial communities with unprecedented resolution but also to explore their clinical relevance.”
Results of the Seventh Scientific Workshop of ECCO: Precision Medicine in IBD—What, Why, and How
Fiocchi, C., Dragoni, G., Iliopoulos, D., Katsanos, K. H., Hernández, V., Suzuki, K., Verstockt, B., Fiocchi, C., Torres, J., & Scharl, M. M. (2021) · Journal of Crohn s and Colitis · doi:10.1093/ecco-jcc/jjab051 · Cited by 57
Joseph, T., Chlenski, P., Litman, A., Korem, T., & Pe’er, I. (2022) · Genome Research · doi:10.1101/gr.275533.121 · Cited by 60
“To this end, we considered 1304 metagenomic samples from 106 individuals in a case-control study of IBD (Lloyd-Price et al. 2019).”
BackgroundMethodResultInfluentialBorder Control: The Role of the Microbiome in Regulating Epithelial Barrier Function
Schreiber, F., Balas, I., Robinson, M. J., & Bakdash, G. (2024) · Cells · doi:10.3390/cells13060477 · Cited by 58
“In a longitudinal study in both UC and CD patients showed a reduction in the tryptophan metabolite indole-3-propionic acid (IPA) in UC patients in comparison to non-IBD individuals [99].”
ResultMulticenter assessment of shotgun metagenomics for pathogen detection
Liu, D., Zhou, H., Xu, T., Yang, Q., Mo, X., Shi, D., Ai, J., Zhang, J., Tao, Y., Wen, D., et al. (2021) · EBioMedicine · doi:10.1016/j.ebiom.2021.103649 · Cited by 58
Pan, L., Fu, T., Cheng, H., Mi, J., Shang, Q., & Yu, G. (2021) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2021.118921 · Cited by 53
Eloe‐Fadrosh, E. A., Ahmed, F., Anubhav, N., Babinski, M., Baumes, J., Borkum, M., Bramer, L., Canon, R. S., Christianson, D., Corilo, Y., et al. (2022) · Nucleic Acids Research · doi:10.1093/nar/gkab990 · Cited by 85
Advanced Nanomedicine: Redefining Therapeutic Paradigms for Inflammatory Bowel Disease
Zhang, Y., Wang, T., Sun, M., Song, Y., Huang, X., Zhang, S., Yang, J., & Zhang, J. (2023) · Advanced Healthcare Materials · doi:10.1002/adhm.202300069 · Cited by 57
Immunomodulatory Properties of Vitamin D in the Intestinal and Respiratory Systems
Hamza, F. N., Daher, S., Fakhoury, H. M. A., Grant, W. B., Kvietys, P. R., & AlKattan, K. M. (2023) · Nutrients · doi:10.3390/nu15071696 · Cited by 59
Wang, C., Gu, Y., Chu, Q., Wang, X., Ding, Y., Qin, X., Liu, T., Wang, S., Liu, X., Wang, B., et al. (2024) · Microbiological Research · doi:10.1016/j.micres.2024.127660 · Cited by 58
Ambat, A., Antony, L., Maji, A., Ghimire, S., Mattiello, S. P., Kashyap, P., More, S., Sebastian, V., & Scaria, J. (2024) · Gut Microbes · doi:10.1080/19490976.2024.2382324 · Cited by 59
“Thus, to know the association of 27 selected species in this study to IBD, a disease prevalent in both developed and developing countries 28 [37], the abundance of those bacteria was assessed in fecal metagenomes collected from both IBD 29 and non-IBD individuals as a part of a longitudinal cohort study conducted by L…”
BackgroundInfluentialBioorthogonal conjugation and responsive nanocoating of probiotics for inflammatory bowel disease
Peng, P., Feng, T., Yang, X., Ding, R., Wang, J., Chen, P., Guo, Y., & Li, P. (2024) · Journal of Controlled Release · doi:10.1016/j.jconrel.2024.08.036 · Cited by 52
Fu, W., Huang, Z., Li, W., Xu, L., Yang, M., Ma, Y., Liu, H., Qian, H., & Wang, W. (2024) · Bioactive Materials · doi:10.1016/j.bioactmat.2024.12.004 · Cited by 100
“(3 ) Microbial Imbalance: growing evidence shows that intestinal inflammation and permeability issues caused by microbial imbalance play important roles in the progression of IBD [13].”
The tumor microbiome in cancer progression: mechanisms and therapeutic potential
Zhang, W., Xiang, Y., Ren, H., Liu, Y., Wang, Q., Ran, M., Zhou, W., Lu, T., Zheng, X., Qiao, C., et al. (2025) · Molecular Cancer · doi:10.1186/s12943-025-02403-w · Cited by 64
“Taxonomically, it belongs to the order Clostridiales , which further increases the diversity of microbial genomes [28].”
Gut micro-organisms associated with health, nutrition and dietary interventions
Asnicar, F., Manghi, P., Fackelmann, G., Baldanzi, G., Bakker, E., Ricci, L., Piccinno, G., Piperni, E., Mladenović, K., Amati, F., et al. (2025) · Nature · doi:10.1038/s41586-025-09854-7 · Cited by 79
“Among the 44 known SGBs, several species were already linked with detrimental effects on the host, including Ruminococcus gnavus 26 , Flavonifractor plautii 27 , Ruminococcus torques 28,29 and Enterocloster bolteae 30 .”
Translating the gut microbiome: ready for the clinic?
Lynch, S. V., Ng, S. C., Shanahan, F., & Tilg, H. (2019) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-019-0204-0 · Cited by 57
Li, W., Sun, Y., Dai, L., Chen, H., Yi, B., Niu, J., Wang, L., Zhang, F., Luo, J., Wang, K., et al. (2021) · BMC Microbiology · doi:10.1186/s12866-021-02201-6 · Cited by 58
“However, the pathogenesis of IBD remains unclear, although may be related to the dysregulation of the internal mucosal environment due to changes in host genes, environmental factors, gut microbes, and immune responses [1, 28, 31, 35, 42, 45].”
BackgroundMicrobiota alters the metabolome in an age- and sex- dependent manner in mice
Brown, K., Thomson, C. A., Wacker, S., Drikic, M., Groves, R., Fan, V., Lewis, I. A., & McCoy, K. D. (2023) · Nature Communications · doi:10.1038/s41467-023-37055-1 · Cited by 49
Abbas‐Egbariya, H., Haberman, Y., Braun, T., Hadar, R., Denson, L. A., Gal‐Mor, O., & Amir, A. (2022) · Genome biology · doi:10.1186/s13059-022-02637-7 · Cited by 53
“This may be due to the lower bacterial biomass observed in IBD feces [2, 52, 53], thus leading to an increased fraction of bacteria present in swallowed saliva, or that some of these oral bacteria affect the gut immune response.”
BackgroundSelf-citationDu, C., Wang, K., Zhao, Y., Nan, X., Chen, R., Quan, S., & Xiong, B. (2022) · Nutrients · doi:10.3390/nu14091808 · Cited by 56
“Individuals with IBD are associated with intestinal microbiota disorders and a decreased content of short-chain fatty acids (SCFAs) metabolites [4].”
BackgroundŚwirkosz, G., Szczygieł, A., Logoń, K., Wrześniewska, M., & Gomułka, K. (2023) · Biomedicines · doi:10.3390/biomedicines11123144 · Cited by 68
Sedanolide alleviates DSS-induced colitis by modulating the intestinal FXR-SMPD3 pathway in mice
Li, S., Zhuge, A., Chen, H., Han, S., Shen, J. F., Wang, K., Xia, J., He, X., Jiang, S., Wu, Y., et al. (2024) · Journal of Advanced Research · doi:10.1016/j.jare.2024.03.026 · Cited by 65
“…of Proteobacteria and Enterobacteriaceae , the reduction in Firmicutes , including Clostridiales , and the changes in other taxa after DSS administration observed in our experiments are thought to influence the capacity of the gut flora to generate protective metabolites, especially BAs [71,72].”
Wirbel, J., Essex, M., Forslund, S. K., & Zeller, G. (2024) · Genome biology · doi:10.1186/s13059-024-03390-9 · Cited by 71
Tang, X., Huang, Y., Zhu, Y., & Xu, Y. (2025) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2025.1610435 · Cited by 67
Kaczmarczyk, O., Dąbek, A., Woźniakiewicz, M., Paśko, P., Dobrowolska‐Iwanek, J., Woźniakiewicz, A., Piątek-Guziewicz, A., Zagrodzki, P., Mach, T., & Zwolinska-Wcislo, M. M. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10204701 · Cited by 55
He, Y., Huang, L., Jiang, P., Xu, G., & Sun, T. (2022) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2022.115240 · Cited by 50
Maldonado‐Contreras, A., Noel, S. E., Ward, D. V., Velez, M., & Mangano, K. M. (2020) · Journal of the Academy of Nutrition and Dietetics · doi:10.1016/j.jand.2020.04.018 · Cited by 56
Broadly effective metabolic and immune recovery with C5 inhibition in CHAPLE disease
Ozen, A., Kasap, N., Vujkovic-Cvijin, I., Apps, R., Cheung, F., Karakoç-Aydıner, E., Akkelle, B. Ş., Sarı, S., Tutar, E., Özçay, F., et al. (2021) · Nature Immunology · doi:10.1038/s41590-020-00830-z · Cited by 50
de Oliveira, A. M., Lourenço, T. G. B., & Colombo, A. P. V. (2021) · Journal of Periodontology · doi:10.1002/jper.21-0078 · Cited by 55
Gut microbiome ADP-ribosyltransferases are widespread phage-encoded fitness factors
Brown, E., Arellano-Santoyo, H., Temple, E. R., Costliow, Z. A., Pichaud, M., Hall, A. B., Liu, K., Durney, M. A., Gu, X., Plichta, D. R., et al. (2021) · Cell Host & Microbe · doi:10.1016/j.chom.2021.07.011 · Cited by 50
Self-citationTrpNet: Understanding Tryptophan Metabolism across Gut Microbiome
Lu, Y. P., Chong, J., Shen, S., Chammas, J.-B., Chalifour, L. E., & Xia, J. (2021) · Metabolites · doi:10.3390/metabo12010010 · Cited by 50
“org, accessed on 17 October 2021) [61].”
Human Male Genital Tract Microbiota
Zuber, A., Peric, A., Pluchino, N., Baud, D., & Stojanov, M. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24086939 · Cited by 60
Luo, W., Zhao, M., Dwidar, M., Gao, Y., Xiang, L., Wu, X., Medema, M. H., Xu, S., Li, X., Schäfer, H., et al. (2024) · Microbiome · doi:10.1186/s40168-024-01873-2 · Cited by 58
“Although the precise etiology remains elusive, it is believed to result from dysregulated mucosal immune responses triggered by gut bacteria, especially in individuals with genetic predispositions [3, 4].”
BackgroundResultBiagioli, M., Giorgio, C. D., Massa, C., Marchianò, S., Bellini, R., Bordoni, M., Urbani, G., Roselli, R., Lachi, G., Morretta, E., et al. (2024) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2024.117731 · Cited by 57
Overmyer, K. A., Rhoads, T. W., Merrill, A. E., Ye, Z., Westphall, M. S., Acharya, A., Shukla, S. K., & Coon, J. J. (2021) · Molecular & Cellular Proteomics · doi:10.1016/j.mcpro.2021.100126 · Cited by 51
“These methods can provide clues to how microbes might interact within the biofilm, but importantly, these conclusions are greatly strengthened by biomolecule measurements, for example, when metagenomics is paired with metabolomics (18, 19).”
BackgroundOpportunities and limits of combining microbiome and genome data for complex trait prediction
Pérez-Enciso, M., Zingaretti, L. M., Ramayo‐Caldas, Y., & Campos, G. D. L. (2021) · Genetics Selection Evolution · doi:10.1186/s12711-021-00658-7 · Cited by 64
Huo, D., Cen, C., Chang, H., Ou, Q., Jiang, S., Pan, Y., Chen, K., & Zhang, J. (2021) · Communications Biology · doi:10.1038/s42003-021-02587-z · Cited by 52
Elkrief, A., Waters, N. R., Smith, N., Dai, A., Slingerland, J., Aleynick, N., Febles, B., Gogia, P., Socci, N. D., Lumish, M., et al. (2024) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-23-0498 · Cited by 48
Current Capabilities of Gut Microbiome–Based Diagnostics and the Promise of Clinical Application
Damhorst, G. L., Adelman, M. W., Woodworth, M. H., & Kraft, C. S. (2021) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiaa689 · Cited by 47
Mao, Q., Pan, H., Zhang, Y., Zhang, Y., Zhu, Q., Hong, Y., Huang, Z., Li, Y., Xu, F., Fang, Y., et al. (2022) · Bioactive Materials · doi:10.1016/j.bioactmat.2022.04.001 · Cited by 58
“main phylum in the intestinal flora, during the progression of IBD, the abundance of beneficial Bacteroidetes and Firmicutes would significantly decrease in the intestinal environment of IBD, while the abundance of harmful Verrucomicrobia would significantly increase [63,64], which”
BackgroundGubatan, J. M. B., Boye, T. L., Temby, M., Sojwal, R. S., Holman, D., Sinha, S. R., Rogalla, S., & Nielsen, O. H. (2022) · Microorganisms · doi:10.3390/microorganisms10071371 · Cited by 52
Microbial sensing in the intestine
Wan, T., Wang, Y., He, K., & Zhu, S. (2023) · Protein & Cell · doi:10.1093/procel/pwad028 · Cited by 51
A digital twin of the infant microbiome to predict neurodevelopmental deficits
Sizemore, N., Oliphant, K., Zheng, R., Martin, C. R., Claud, E. C., & Chattopadhyay, I. (2024) · Science Advances · doi:10.1126/sciadv.adj0400 · Cited by 59
Li, P., Zhu, L., Song, C., Wu, M., Zhu, X., He, S., Hu, B., Chen, Z., Liu, Z., Luo, B., et al. (2025) · ACS Nano · doi:10.1021/acsnano.5c00574 · Cited by 52
Shaheen, N., Miao, J., Xia, B., Zhao, Y., & Zhao, J. (2025) · The FASEB Journal · doi:10.1096/fj.202500295r · Cited by 59
“IBD patients exhibit a significant reduction in commensal gut microbiota, which play critical roles in host health and function [57].”
Veillonella intestinal colonization promotes C. difficile infection in Crohn’s disease
Yang, Z., Wang, J., Chen, Y., Chen, T., Shen, Z., Wang, Y., Jian, Y., Xiang, G., Ma, X., Zhao, N., et al. (2025) · Cell Host & Microbe · doi:10.1016/j.chom.2025.07.019 · Cited by 54
Kedia, S., Ghosh, T. S., Jain, S., Desigamani, A., Kumar, A., Gupta, V., Bopanna, S., Yadav, D. P., Goyal, S., Makharia, G. K., et al. (2020) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.15232 · Cited by 48
Smith, B. J., Piceno, Y. M., Zydek, M., Zhang, B., Syriani, L. A., Terdiman, J. P., Kassam, Z., Ma, A. I., Lynch, S. V., Pollard, K. S., et al. (2022) · Scientific Reports · doi:10.1038/s41598-022-09307-5 · Cited by 50
“While shortcomings of the Mantel test have been documented [67], the method has been applied in past studies linking different features of the microbiome [68].”
MethodInterplays between drugs and the gut microbiome
Wan, Y., & Zuo, T. (2022) · Gastroenterology report · doi:10.1093/gastro/goac009 · Cited by 48
Huang, J., Zhang, J., Wang, F., Zhang, B., & Tang, X. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1008146 · Cited by 50
“It is well known that microbial dysregulation has been increasingly appreciated in the pathogenesis of inflammatory bowel diseases (35, 36), and antibiotics used to modulate gut microbes and fecal microbiota transplantation have been considered to treat UC (37).”
BackgroundVitamin B5 rewires Th17 cell metabolism via impeding PKM2 nuclear translocation
Chen, C., Zhang, W., Zhou, T., Liu, Q., Han, C., Huang, Z., Chen, S., Mei, Q., Zhang, C., Zhang, K., et al. (2022) · Cell Reports · doi:10.1016/j.celrep.2022.111741 · Cited by 58
Mah, C., Jayawardana, T. C., Leong, G. M., Koentgen, S., Lemberg, D. A., Connor, S. J., Rokkas, T., Grimm, M., Leach, S. T., & Hold, G. L. (2023) · Pathogens · doi:10.3390/pathogens12020262 · Cited by 57
Liang, T. G., Huang, C., Fu, W., Gao, L., Mi, N., Bai, M., Ma, H., Zhang, C., Lu, Y., Zhao, J., et al. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1217306 · Cited by 52
Godny, L., Elial-Fatal, S., Arrouasse, J., Fischler, T. S., Reshef, L., Kutukov, Y., Cohen, S., Pfeffer‐Gik, T., Barkan, R., Shakhman, S. R., et al. (2025) · Gastroenterology · doi:10.1053/j.gastro.2024.12.031 · Cited by 56
Tseng, C., Wong, S. H., Yu, J. Q., Lee, Y. Y., Terauchi, J., Lai, H., Luo, J., Kao, C., Yu, S., Liou, J., et al. (2025) · Gut · doi:10.1136/gutjnl-2024-334501 · Cited by 54
“1 Various non-infectious diseases (eg, obesity, cardio-vascular disease, inflammatory bowel disease) have been attributed to an imbalanced microbiome, 2–4 suggesting that a well-balanced microbiome could hold therapeutic promise.”
Spatial Design of Polymicrobial Oral Biofilm in Its Native Disease State
Kim, D.-M., & Koo, H. (2020) · Journal of Dental Research · doi:10.1177/0022034520909313 · Cited by 49
“Furthermore, technological advances using realtime microscopy-spectroscopy methods combined with an integrative multiomics approach (Lloyd-Price et al. 2019; Zhou et al. 2019) provide exciting opportunities to precisely assess the function of the structured community and how it coordinates the disease process spatiote…”
BackgroundGhavami, S. B., Yadegar, A., Aghdaei, H. A., Sorrentino, D. R., Farmani, M., Mir, A., Azimirad, M., Balaii, H., Shahrokh, S., & Zali, M. R. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21176266 · Cited by 51
“Inflammatory bowel diseases (IBD), including Crohn’s disease (CD) and ulcerative colitis (UC), are chronic, relapsing disorders thought to be multifactorial in origin and involve host immunity, genetic, microbial and environmental factors [1,2].”
BackgroundFang, X. D., Vázquez‐Baeza, Y., Elijah, E. O., Vargas, F., Ackermann, G. L., Humphrey, G., Lau, R., Weldon, K. C., Sanders, J. G., Panitchpakdi, M. W., et al. (2020) · Inflammatory Bowel Diseases · doi:10.1093/ibd/izaa262 · Cited by 48
Self-citationThe gut microbiome as a target for adjuvant therapy in obstructive sleep apnea
Badran, M., Mashaqi, S., & Gozal, D. (2020) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2020.1841749 · Cited by 47
Miao, F., Shan, C., Ma, T., Geng, S., & Ning, D. (2021) · Microbial Pathogenesis · doi:10.1016/j.micpath.2021.104866 · Cited by 48
Misra, N., Clavaud, C., Guinot, F., Bourokba, N., Nouveau, S., Mezzache, S., Palazzi, P., Appenzeller, B. M. R., Tenenhaus, A., Leung, M. H. Y., et al. (2021) · Scientific Reports · doi:10.1038/s41598-021-97572-1 · Cited by 40
Feng, J., Wang, Y., Lv, Y., Fang, S., Ren, M., Yao, M., Lan, M., Zhao, Y., & Gao, F. (2022) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.2c00550 · Cited by 45
Wen, H., Li, L., Ge, X., Yang, F., Li, Y., Li, M., Xiao, W., & Luo, Z. Y. (2023) · Advanced Functional Materials · doi:10.1002/adfm.202212566 · Cited by 45
Reconstruction of the personal information from human genome reads in gut metagenome sequencing data
Tomofuji, Y., Sonehara, K., Kishikawa, T., Maeda, Y., Ogawa, K., Kawabata, S., Nii, T., Okuno, T., Oguro-Igashira, E., Kinoshita, M., et al. (2023) · Nature Microbiology · doi:10.1038/s41564-023-01381-3 · Cited by 50
Protein/polysaccharide-based hydrogels loaded probiotic-mediated therapeutic systems: A review
Zheng, B.-D., Gan, L., Tian, L.-Y., & Chen, G. (2023) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2023.126841 · Cited by 53
The oral-gut microbiome axis in inflammatory bowel disease: from inside to insight
Wang, A., Zhai, Z., Ding, Y., Wei, J., Wei, Z., & Cao, H. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1430001 · Cited by 68
Gut microbiota and epigenetic inheritance: implications for the development of IBD
Guo, X., Li, J., Xu, J., Zhang, L., Huang, C., Nie, Y., & Zhou, Y. (2025) · Gut Microbes · doi:10.1080/19490976.2025.2490207 · Cited by 55
Chiu, C., Chou, H., Chang, L., Fan, W., Dinh, M. C. V., Kuo, Y., Chung, W., Lai, H., Hsieh, W., & Su, S. (2020) · Allergy · doi:10.1111/all.14438 · Cited by 46
Zhuang, X., Tian, Z., Feng, R., Li, M., Li, T., Zhou, G., Qiu, Y., Chen, B., He, Y., Chen, M., et al. (2020) · Inflammatory Bowel Diseases · doi:10.1093/ibd/izaa253 · Cited by 52
Sionov, R. V., & Steinberg, D. (2022) · Biomedicines · doi:10.3390/biomedicines10030631 · Cited by 53
Harnessing the Potential of Multiomics Studies for Precision Medicine in Infectious Disease
Ward, R., Aghaeepour, N., Bhattacharyya, R. P., Clish, C. B., Gaudilliere, B. L., Hacohen, N., Mansour, M. K., Mudd, P. A., Pasupneti, S., Presti, R. M., et al. (2021) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofab483 · Cited by 46
Self-citationWahida, A., Müller, M., Hiergeist, A., Popper, B., Steiger, K., Branca, C., Tschurtschenthaler, M., Engleitner, T., Donakonda, S., Coninck, J. D., et al. (2021) · Science Immunology · doi:10.1126/sciimmunol.abf7235 · Cited by 49
Gut microbiota analysis for prediction of clinical relapse in Crohn’s disease
Buffet‐Bataillon, S., Bouguen, G., Fleury, F., Cattoir, V., & Cunff, Y. L. (2022) · Scientific Reports · doi:10.1038/s41598-022-23757-x · Cited by 50
Functional host-specific adaptation of the intestinal microbiome in hominids
Rühlemann, M. C., Bang, C., Gogarten, J. F., Hermes, B. M., Groussin, M., Waschina, S., Poyet, M., Ulrich, M., Akoua-Koffi, C. G., Deschner, T., et al. (2024) · Nature Communications · doi:10.1038/s41467-023-44636-7 · Cited by 52
Iacucci, M., Santacroce, G., Maeda, Y., & Ghosh, S. (2025) · Gastroenterology · doi:10.1053/j.gastro.2025.03.005 · Cited by 56
Targeting symbionts by apolipoprotein L proteins modulates gut immunity
Tao, Y., Hu, X., Cao, F., Yun, F., Jia, K., Zhang, M., Kong, G., Nie, B., Liu, Y., Zhang, H., et al. (2025) · Nature · doi:10.1038/s41586-025-08990-4 · Cited by 54
“In addition, we investigated the presence of the Cer1P biosynthetic pathway in other Bacteroidales species used in our study, as well as datasets from the Human Micro-biome Project 36 .”
Emerging Therapies in Inflammatory Bowel Disease: A Comprehensive Review
Appiah, J. K., Hayat, U., Garg, N., Asante, R., Donneyong, E., Haider, M. U., Patel, P., Khan, Z. H., & Siddiqui, A. A. (2025) · Journal of Clinical Medicine · doi:10.3390/jcm14176119 · Cited by 58
Advanced In Vitro Testing Strategies and Models of the Intestine for Nanosafety Research
Kämpfer, A. A. M., Busch, M., & Schins, R. P. F. (2020) · Chemical Research in Toxicology · doi:10.1021/acs.chemrestox.0c00079 · Cited by 47
Station and train surface microbiomes of Mexico City’s metro (subway/underground)
Hernández, A. M., Vargas-Robles, D., Alcaraz, L. D., & Peimbert, M. (2020) · Scientific Reports · doi:10.1038/s41598-020-65643-4 · Cited by 49
Gut instincts: vitamin D/vitamin D receptor and microbiome in neurodevelopment disorders
Ogbu, D., Xia, E., & Sun, J. (2020) · Open Biology · doi:10.1098/rsob.200063 · Cited by 49
“A potential biomarker includes intermediate products of tryptophan such as kynurenine, kynurenic acid (KA) and xanthurenic acid (XA) [6].”
BackgroundRavegnini, G., Fosso, B., Saverio, V. D., Sammarini, G., Zanotti, F., Rossi, G., Ricci, M., D’Amico, F., Valori, G., Ioli, A., et al. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21249735 · Cited by 51
“Indeed, the interaction between microbiota and host cells along the GC tract is a key player in influencing and modulating the immune system [27–30], with many reports showing changes in the microbiota composition in different inflammatory-sustained conditions [31,32].”
BackgroundShute, A., Callejas, B. E., Li, S., Wang, A., Jayme, T. S., Ohland, C., Lewis, I. A., Layden, B. T., Buret, A. G., & McKay, D. M. (2021) · Microbiome · doi:10.1186/s40168-021-01146-2 · Cited by 53
“We hypothesized that the anti-colitic effect of infection with a helminth parasite could be influenced by the gut microbiota and so its effectiveness would be reduced in IBD patients with dysbiosis [35].”
BackgroundMillet, V., Gensollen, T., Maltese, M., Serrero, M., Lesavre, N., Bourges, C., Pitaval, C., Cadra, S., Chasson, L., Manh, T. V., et al. (2022) · Gut · doi:10.1136/gutjnl-2021-325792 · Cited by 46
Wang, E.-J., Wu, M.-Y., Ren, Z., Zheng, Y., Ye, R. D., Tan, C. S. H., Wang, Y., & Lu, J. (2023) · Burns & Trauma · doi:10.1093/burnst/tkad004 · Cited by 48
Microbiota-assisted iron uptake promotes immune tolerance in the intestine
Zhu, L., Li, G., Liang, Z., Qi, T., Deng, K., Yu, J., Peng, Y., Zheng, J., Song, Y., & Chang, X. (2023) · Nature Communications · doi:10.1038/s41467-023-38444-2 · Cited by 51
Feng, R., Tian, Z., Mao, R., Ma, R., Luo, W., Zhao, M., Li, X., Liu, Y., Huang, K., Xiang, L., et al. (2023) · Journal of Crohn s and Colitis · doi:10.1093/ecco-jcc/jjad098 · Cited by 48
Challenges in IBD Research 2024: Preclinical Human IBD Mechanisms
Ciorba, M. A., Konnikova, L., Hirota, S. A., Lucchetta, E. M., Turner, J. R., Slavin, A., Johnson, K., Condray, C. D., Hong, S., Cressall, B. K., et al. (2024) · Inflammatory Bowel Diseases · doi:10.1093/ibd/izae081 · Cited by 47
Older, E. A., Zhang, J., Ferris, Z. E., Xue, D., Zhong, Z., Mitchell, M. K., Madden, M., Wang, Y., Chen, H., Nagarkatti, P. S., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-53670-y · Cited by 50
“Using metabolomics data from two independent datasets (dataset 1: IBDMDB 19,39 , corresponding to the same dataset used for metagenomics and metatranscriptomics analysis; dataset 2: PRISM 40 ), we identi fi ed metabolite features putatively corresponding to speci fi c sulfonolipids 16,41…”
InfluentialHost-directed therapy for tuberculosis
Tian, N., Chu, H., Li, Q., Sun, H., Zhang, J., Chu, N., & Sun, Z. (2025) · European journal of medical research · doi:10.1186/s40001-025-02443-4 · Cited by 54
“…active form, 1,25(OH)2D, regulates mucosal immunity, host defense, and inflammation by binding to the vitamin D receptor (VDR) in macrophages [73, 74], triggering the expres - sion of the antimicrobial peptide cathelicidin (CAMP) (LL-37) and promoting autophagosome–lysosome fusion and maturation…”
Multi-omics time-series analysis in microbiome research: a systematic review
Sherwani, M. K., Ruuskanen, M. O., Feldner-Busztin, D., Firbas, P., Boza, G., Móréh, Á., Borman, T., Erawijantari, P. P., Scheuring, I., Gopalakrishnan, S., et al. (2025) · Briefings in Bioinformatics · doi:10.1093/bib/bbaf502 · Cited by 55
“Several studies used linear mixed models [19, 20, 22, 28, 50, 51, 56, 58–60 , 134] to establish associations between ’omics layers.”
Thomann, A., Mak, J. W. Y., Zhang, J., Wüstenberg, T., Ebert, M. P., Sung, J. J. �., Bernstein, C. N., Reindl, W., & Ng, S. C. (2020) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.15787 · Cited by 47
Volkova, A., & Ruggles, K. V. (2021) · Frontiers in Microbiology · doi:10.3389/fmicb.2021.621310 · Cited by 48
“, 2019), and acylcarnitine (Lloyd-Price et al., 2019) metabolites involved immune response and the microbiome, many of which we also found to be significantly associated with our most predictive taxa.”
BackgroundDubinsky, V., Reshef, L., Rabinowitz, K. M., Yadgar, K., Godny, L., Zonensain, K., Wasserberg, N., Dotan, I., & Gophna, U. (2021) · mSystems · doi:10.1128/msystems.00984-20 · Cited by 47
Metadata
- Authors
- Lloyd-Price, J., Arze, C., Ananthakrishnan, A. N., Schirmer, M., Avila-Pacheco, J., Poon, T. W., Andrews, E., Ajami, N. J., Bonham, K. S., Brislawn, C. J., Casero, D., Courtney, H., Gonzalez, A., Graeber, T. G., Hall, A. B., Lake, K., Landers, C. J., Mallick, H., Plichta, D. R., Prasad, M., Rahnavard, G., Sauk, J., Shungin, D., Vázquez-Baeza, Y., White, R. A., IBDMDB Investigators, Bishai, J., Bullock, K., Deik, A., Dennis, C., Kaplan, J. L., Khalili, H., McIver, L. J., Moran, C. J., Nguyen, L., Pierce, K. A., Schwager, R., Sirota-Madi, A., Stevens, B. W., Tan, W., ten Hoeve, J. J., Weingart, G., Wilson, R. G., Yajnik, V., Braun, J., Denson, L. A., Jansson, J. K., Knight, R., Kugathasan, S., McGovern, D. P. B., Petrosino, J. F., Stappenbeck, T. S., Winter, H. S., Clish, C. B., Franzosa, E. A., Vlamakis, H., Xavier, R. J., & Huttenhower, C.
- Affiliations
- Harvard University (US)
- Massachusetts General Hospital (US)
- Broad Institute (US)
- Baylor College of Medicine (US)
- Pacific Northwest National Laboratory (US)
- University of California, Los Angeles (US)
- Cincinnati Children's Hospital Medical Center (US)
- Cedars-Sinai Medical Center (US)
- Emory University (US)
- University of California San Diego (US)
- Washington University in St. Louis (US)
- Corresponding author
- Huttenhower, Curtis
- ORCID
- Arze, Cesar
- Ananthakrishnan, Ashwin N.
- Schirmer, Melanie
- Ajami, Nadim J.
- Bonham, Kevin S.
- Brislawn, Colin J.
- Casero, David
- Graeber, Thomas G.
- Hall, A. Brantley
- Mallick, Himel
- Plichta, Damian R.
- Sauk, Jenny
- Shungin, Dmitry
- Bullock, Kevin
- Deik, Amy
- Khalili, Hamed
- McIver, Lauren J.
- Nguyen, Long
- Pierce, Kerry A.
- Yajnik, Vijay
- Knight, Rob
- McGovern, Dermot P. B.
- Winter, Harland S.
- Clish, Clary B.
- Franzosa, Eric A.
- Vlamakis, Hera
- Xavier, Ramnik J.
- Huttenhower, Curtis
- Venue
- Nature
- Published
- 2019-05-29
- Volume
- 569
- Issue
- 7758
- Pages
- 655-662
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- PMC
- PMC6650278
- OpenAlex
- W2947189704
- Cited by
- 3,143
- References
- 101
- Citations by year
- 2026: 500 · 2025: 555 · 2024: 498 · 2023: 402 · 2022: 441 · 2021: 452 · 2020: 247 · 2019: 42
- FWCI
- 98.40
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0 (tdm)
- creativecommons.org/licenses/by/4.0 (vor)
- Locations
- Nature (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- OSTI OAI (U.S. Department of Energy Office of Scientific and Technical Information) (submittedVersion)
- Digital Access to Scholarship at Harvard (DASH) (Harvard University) (submittedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- eScholarship (California Digital Library) (submittedVersion)
- eScholarship (California Digital Library) (submittedVersion, cc-by)
- Funders
- National Science Foundation (1053486, DEAC05–76RL01830, 76RL01830)
- U.S. Department of Energy (DE-AC05–76RL01830, 76RL01830, AC05-76RL01830, DE-AC05?)
- Battelle (AC05-76RL01830, DE- AC05-76RL01830, DE-AC05)
- Leona M. and Harry B. Helmsley Charitable Trust (P01DK046763, U01DK062413)
- Harvard T.H. Chan School of Public Health
- Crohn's and Colitis Foundation (563526)
- Broad Institute
- Vetenskapsrådet (4.1-2016-00416)
- National Institutes of Health (DBI-1053486, UL1TR001881, DE-AC05-76RL01830)
- National Human Genome Research Institute (R01HG005969)
- National Institute of Diabetes and Digestive and Kidney Diseases (P01DK046763, R24DK110499, U54DK102557, U01DK062413, P30DK078392, P30DK043351, P30DK040561)
- National Institute of Dental and Craniofacial Research (U54DE023798)
- National Center for Advancing Translational Sciences
- Army Research Office (W911NF-11-1-0473, W911NF, W911NF-11)
- Pacific Northwest National Laboratory (DEAC0576RL01830, 76RL01830)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Health Sciences › Medicine › Gastroenterology › Inflammatory Bowel Disease
- Health Sciences › Dentistry › Periodontics › Oral microbiology and periodontitis research
- Keywords
- inflammatory bowel disease, Crohn's disease, ulcerative colitis, gut microbiota, dysbiosis, multi-omics, facultative anaerobes, obligate anaerobes, Clostridia, acylcarnitines, bile acids, short-chain fatty acids, serum antibodies, disease activity, temporal variation, host-microbe interactions
- MeSH terms
- Gastrointestinal Microbiome, Animals, Fungi, Health, Humans, Phylogeny, Species Specificity, Viruses, Inflammatory Bowel Diseases, Transcriptome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.